Analyst firms · BofA Securities · FGEN
BofA Securities FGEN price target and rating history
FibroGen Inc (FGEN) · Health Care
BofA Securities rates FibroGen Inc (FGEN) Underperform with a $2 price target, as of its latest action on Aug 8, 2023. It has published 4 rating actions on FGEN since July 2021, including 1 upgrade and 3 downgrades.
- Current rating
- Underperform
- Price target
- $2
- Median target, all firms
- Too few
- Actions on FGEN
- 4
BofA Securities price target on FGEN
Every BofA Securities rating on FGEN
- Aug 8, 2023
- Jun 26, 2023
- Jan 5, 2023
- Jul 16, 2021
Questions about BofA Securities and FGEN
- What is BofA Securities's price target for FGEN?
- BofA Securities's latest stated price target for FibroGen Inc (FGEN) is $2, from its action on Aug 8, 2023.
- What is BofA Securities's rating on FGEN?
- BofA Securities rates FGEN Underperform, a bearish rating, as of Aug 8, 2023.
- When did BofA Securities last change its view on FGEN?
- On Aug 8, 2023, BofA Securities downgrades to Underperform from Neutral, price target $4 to $2.
More FGEN rating histories
All BofA Securities ratingsFGEN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.